SPIRIVA RESPIMAT, 2.5 mcg, and SPIRIVA HANDIHALER are indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and for reducing COPD exacerbations
Featured Items
View allUse this section to explain a set of product features, to link to a series of pages, or to answer common questions.
Use this section to explain a set of product features, to link to a series of pages, or to answer common questions.